Clinical development plan: indole-3-carbinol.
D000328:Adult; D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000517:prevention & control*; D017322:Clinical Trials, Phase II as Topic; D017277:Drug Approval; D005260:Female; D006801:Humans; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental; D051381:Rats; D017207:Rats, Sprague-Dawley; D012107:Research Design
D016588:Anticarcinogenic Agents; D007211:Indoles; C016517:indole-3-carbinol